Tech Company Financing Transactions
Seven Bridges Funding Round
On 2/17/2016, Seven Bridges raised $45 million in Series A funding from Kryssen Capital and private investors.
Transaction Overview
Company Name
Announced On
2/17/2016
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series A
Investors
Kryssen Capital (Lead Investor)
Proceeds Purpose
The investment will support ongoing innovation of the Seven Bridges Platform, a scalable, cloud-based suite of tools for biomedical data analysis that powers genomic research focused on cancer treatment and precision medicine.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
1 Main St. 5th Floor 500
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Deniz Kural
Chief Technical Officer
Igor Bogicevic
President
James Sietstra
VP - Operations
Bruce Press
Browse more venture capital transactions:
Prev: 2/17/2016: Triptease venture capital transaction
Next: 2/17/2016: Akarna Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs